Thrombin is a coagulation protease that activates platelets, leukocyte
s, endothelial and mesenchymal cells at sites of vascular injury, acti
ng partly through an unusual proteolytically activated G-protein-coupl
ed receptor(1-3). Knockout of the gene encoding this receptor provided
definitive evidence for a second thrombin receptor in mouse platelets
and for tissue-specific roles for different thrombin receptors(4) We
now report the cloning and characterization of a new human thrombin re
ceptor, designated protease-activated receptor 3 (PAR3). PAR3 can medi
ate thrombin-triggered phosphoinositide hydrolysis and is expressed in
a variety of tissues, including human bone marrow and mouse megakaryo
cytes, making it a candidate for the sought-after second platelet thro
mbin receptor. PAR3 provides a new tool for understanding thrombin sig
nalling and a possible target for therapeutics designed selectively to
block thrombotic, inflammatory and proliferative responses to thrombi
n.